Happiness Biotech Group Profit Margin 2019-2021 | HAPP

Current and historical gross margin, operating margin and net profit margin for Happiness Biotech Group (HAPP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Happiness Biotech Group net profit margin as of March 31, 2021 is 0%.
Happiness Biotech Group Annual Profit Margins
Happiness Biotech Group Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.028B $0.071B
Happiness Biotech Group Limited is a nutraceutical and dietary supplements producer. It is focused on the research, development, manufacturing and marketing of products made from Chinese herbal extracts and other ingredients. Happiness Biotech Group Limited is based in NANPING, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.972B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $11.985B 20.30
Biohaven Pharmaceutical Holding (BHVN) United States $8.378B 0.00
Emergent Biosolutions (EBS) United States $2.740B 6.61
Arcus Biosciences (RCUS) United States $2.509B 0.00
Myovant Sciences (MYOV) United Kingdom $1.869B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.763B 0.00
Zymeworks (ZYME) Canada $1.061B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.333B 0.00
Enzo Biochem (ENZ) United States $0.157B 15.43